Research Papers: Gerotarget (Focus on Aging):
Zinc finger factor 521 enhances adipogenic differentiation of mouse multipotent cells and human bone marrow mesenchymal stem cells
Metrics: PDF 960 views | HTML 1328 views | ?
Kuo-Yun Tseng1, Shankung Lin1,2
1Institute of Cellular and System Medicine, National Health Research Institutes, Miaoli, Taiwan, Republic of China
2Graduate Institute of Basic Medical Science, China Medical University, Taichung, Taiwan, Republic of China
Shankung Lin, e-mail: email@example.com
Keywords: aging, marrow MSC, age-related bone loss, osteoporosis, adipogenesis
Received: March 21, 2015 Accepted: April 24, 2015 Published: May 06, 2015
Previously, we found that ZNF521 expression was up-regulated with advancing age in human bone marrow mesenchymal stem cells (bmMSCs). Here, we investigated the regulatory role of ZNF521 in the differentiation of mouse C3H10T1/2 cells and human bmMSCs. Our data show that ZNF521 overexpression repressed osteoblastic differentiation of C3H10T1/2 cells, accompanied by a decrease in Runx2 expression and an increase in PPARγ2 expression. In contrast, ZNF521 overexpression enhanced adipogenic differentiation of C3H10T1/2 cells, concomitant with increased expression of PPARγ2, aP2, adiponectin and C/EBPδ. Chromatin immunoprecipitation followed by quantitative PCR analyses and luciferase reporter assays suggested that ZNF521 overexpression enhances PPARγ2 expression at the transcriptional level. The enhancing effect of ZNF521 overexpression on the adipogenic differentiation of C3H10T1/2 cells was also observed ex vivo. Finally, similar to those noted in C3H10T1/2 cells, ZNF521 overexpression in human bmMSCs was found to promote adipogenic differentiation in vitro and ex vivo, but repressed osteoblastic differentiation in vitro. ZNF521 knockdown significantly repressed adipogenic differentiation in vitro and ex vivo, but promoted osteoblastic differentiation in vitro. We propose that ZNF521 can function as a repressor of osteoblastic differentiation of bmMSCs while promoting adipogenesis, and that elevated ZNF521 expression might play a role in the age-related bone loss.
All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.